Immunohistochemical array for clear cell type mucoepidermoid carcinoma

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Background: The protein expression profile of clear cell type mucoepidermoid carcinoma (MEC) is not well known. Methods: We examined a case of clear cell type MEC by immunohistochemical (IHC) array using 59 antibodies against oncoproteins, proliferation-related proteins, apoptosis-related proteins, growth factor-related proteins, angiogenesis-related proteins, and matrix proteins. Results: MEC tumor cells showed 40 to 60% more expression of BCL-2 and cyclin-dependent kinase 4 than normal gingival tissue, and 20-40% more expression of BCL-2-associated agonist of cell death, deleted in malignant brain tumors 1, E-cadherin, eIF5A, hypoxia-inducible factor, vimentin, and Wnt-1. Expression of other proteins, including p53, epidermal growth factor receptor, proliferating cell nuclear antigen, survivin, carcinoembryonic antigen, β-catenin, poly-ADP ribose-polymerase, etc. were relatively weak in MEC tumor cells. Conclusions: The IHC array for our MEC contained strong oncogenic signals involving Wnt-1/ adenomatous polyposis coli, tumor necrosis factor α/signal transducer and activator of transcription 3/BCL-2, and pAKT pathways, signals that could result in the prolonged survival of clear tumor cells. © 2010. Korean Association of Medical Journal Editors.

Author supplied keywords

Cite

CITATION STYLE

APA

Kim, Y. S., Lee, S. S., Song, J. Y., Kim, E. C., & Lee, S. K. (2010). Immunohistochemical array for clear cell type mucoepidermoid carcinoma. Korean Journal of Pathology, 44(3), 284–294. https://doi.org/10.4132/KoreanJPathol.2010.44.3.284

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free